The Ohio mother and former teacher used her final months to write lessons for her sons and to help others living with ...

At 71 years old, facing a terminal diagnosis, Colorado resident Tom Pringle has one more thing he wants to do before he dies: ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

Before Sara Bennett died of ALS in January, the late content creator posted about the advice and heartfelt words that she ...

Sara Bennett, 39, lived in motion -- teaching, leading, advocating and pouring into others until the very end.

The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...

The central Ohio community can support the Bennett family by contributing to a Meal Train and donating to college funds for ...

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

Jamie-Lynn Sigler, who has lived with multiple sclerosis for more than two decades, says she felt a deep sense of gratitude ...

NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).